Total bilirubin as a marker for hemolysis and outcome in patients with severe ARDS treated with veno-venous ECMO
Patients with ARDS, vvECMO-therapy and tBili > 3.6mg/dl had a higher mortality and lower chances for recovery from organ dysfunction, RRT, and ECMO within 28 days. The tBili-cut-off value may be useful to identify patients at risk for unfavorable outcomes.
Authors
- Victoria Bünger (ORCID: https://orcid.org/0000-0003-3557-2423)
- Alexander Krannich (ORCID: https://orcid.org/0000-0002-4025-6495)
- Claudia Spies (ORCID: https://orcid.org/0000-0002-1062-0495)
- Jan A. Graw (ORCID: https://orcid.org/0000-0002-6920-8868)
- Wolfgang M. Kuebler (ORCID: https://orcid.org/0000-0003-4100-2961)
- Steffen Weber‐Carstens (ORCID: https://orcid.org/0000-0001-7405-0172)
- Felix Balzer (ORCID: https://orcid.org/0000-0003-1575-2056)
- Oliver Hunsicker (ORCID: https://orcid.org/0000-0002-3998-409X)
- Mario Menk (ORCID: https://orcid.org/0000-0003-1340-9211)
Institutions
- Humboldt-Universität zu Berlin (DE)
- University Hospital Ulm (DE)
- University Hospital Carl Gustav Carus (DE)
- Freie Universität Berlin (DE)
- Technische Universität Dresden (DE)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- BMC Anesthesiology
- Published
- 2025-03-13
- DOI
- https://doi.org/10.1186/s12871-025-02988-1
- Citations
- 2
- Primary Topic
- Mechanical Circulatory Support Devices
- Type
- article
- Field-Weighted Citation Impact
- 1.35
Funders
- Deutsche Forschungsgemeinschaft